Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

Share this content:

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
New York Presbyterian Hospital
Weill Medical College of Cornell University

Contact
Guido Dalbagni, MD     
646-422-4394
     
Harry Herr, MD     
646-422-4411

Investigator
Guido Dalbagni, MD     
Memorial Sloan-Kettering Cancer Center

ClinicalTrials.gov Identifier
NCT00974818

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.